Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Lasers in Medical Science

• Publication date

  2015-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10103-014-1703-4PMID 25563461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.

  2014cited by this paper
• Nanophotosensitizers toward advanced photodynamic therapy of Cancer.

  2013cited by this paper
• The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells

  2013cited by this paper
• Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

  2013cited by this paper
• Adjuvant intraoperative photodynamic therapy in head and neck cancer.

  2013cited by this paper
• Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

  2013cited by this paper
• PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy.

  2013cited by this paper
• mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.

  2013influential reference
• A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

  2013cited by this paper
• Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.

  2012influential reference
• Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3

  2012cited by this paper
• mTHPC‐mediated Photodynamic Treatment Up‐regulates the Cytokines VEGF and IL‐1alpha

  2012cited by this paper
• In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.

  2012cited by this paper
• A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method

  2012cited by this paper
• Liposomal nanostructures for photosensitizer delivery

  2011cited by this paper
• Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer †,‡

  2011cited by this paper
• Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma

  2011cited by this paper
• Photodynamic Therapy Using an Anti-EGF Receptor Antibody Complexed with Verteporfin Nanoparticles: A Proof of Concept Study

  2011cited by this paper
• Photodynamic therapy of cancer: An update

  2011cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper
• Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window‐chamber tumor model

  2011cited by this paper
• Disulfonated tetraphenyl chlorin (TPCS_2a), a novel photosensitizer developed for clinical utilization of photochemical internalization

  2011cited by this paper
• Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.

  2011cited by this paper
• Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model

  2011cited by this paper
• Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells

  2011cited by this paper
• Targeted photodynamic therapy — a promising strategy of tumor treatment

  2011influential reference
• Biology of vascular endothelial growth factor and its receptors in head and neck cancer: Beyond angiogenesis

  2011cited by this paper
• PHOTOFRIN‐mediated photodynamic therapy for treatment of early stage (Tis‐T2N0M0) SqCCa of oral cavity and oropharynx

  2010cited by this paper
• Photodynamic therapy of head and neck cancers.

  2010influential reference
• The application and challenges of clinical PD-PDT in the head and neck region: a short review.

  2010influential reference
• Development and applications of photo-triggered theranostic agents.

  2010cited by this paper
• Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study

  2010cited by this paper
• The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation

  2010cited by this paper
• The surgical palliation of advanced head and neck cancer using photodynamic therapy.

  2010influential reference
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

  2010cited by this paper
• Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.

  2010cited by this paper
• Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.

  2009cited by this paper
• Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.

  2009cited by this paper
• Photocytotoxicity of mTHPC (Temoporfin) Loaded Polymeric Micelles Mediated by Lipase Catalyzed Degradation

  2008cited by this paper
• Head and neck cancer

  2008influential reference
• Effect of Photosensitizer Dose on Fluence Rate Responses to Photodynamic Therapy †

  2007cited by this paper
• Photochemical internalization: a new tool for drug delivery.

  2007cited by this paper
• Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation

  2007cited by this paper
• Photodynamic therapy of feline cutaneous squamous cell carcinoma using a newly developed liposomal photosensitizer: preliminary results concerning drug safety and efficacy.

  2007cited by this paper
• Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.

  2006cited by this paper
• Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors

  2006cited by this paper
• Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

  2006cited by this paper
• Optimizing Photodynamic Therapy: In vivo Pharmacokinetics of Liposomal meta-(Tetrahydroxyphenyl)Chlorin in Feline Squamous Cell Carcinoma

  2005cited by this paper
• Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors

  2004cited by this paper
• Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.

  2003cited by this paper
• Comparison of the in vivo efficiency of photofrin II‐, mTHPC‐, mTHPC‐PEG‐ and mTHPCnPEG‐mediated PDT in a human xenografted head and neck carcinoma

  2001cited by this paper
• Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity.

  2000cited by this paper
• Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.

  1993cited by this paper

• Enhanced Antitumor Efficacy of a Combination of Immunotoxin and Photosensitizer Under Illumination in Xenograft Mice

  2026cites this paper
• Case Report: Photodynamic therapy meets Chinese herbal medicine: a promising approach for advanced hypopharyngeal carcinoma

  2025cites this paper
• Photodynamic Therapy Using a Heavy-Atom-Free G‑Quadruplex-Targeted Photosensitizer to Efficiently Regress Rhabdomyosarcoma Tumors In Vivo.

  2025cites this paper
• Passive and Active Tumor Targeting in Photodynamic Therapy of Cancer: Mini-Review

  2024cites this paper
• Perspectives on photodynamic therapy combined with immunotherapy in treatment of colorectal cancer: an overview based on experimental studies.

  2024cites this paper
• Assessment of the methylene blue mediated photodynamic therapy on BCL2 and BAX genes expression at mRNA level and apoptosis of head and neck squamous cell carcinoma cell line.

  2022cites this paper
• Current Insights and Progress in the Clinical Management of Head and Neck Cancer

  2022cites this paper
• Tumor cell-specific retention of photosensitizers determines the outcome of photodynamic therapy for head and neck cancer.

  2022cites this paper
• Cancer stem cells targets and combined therapies to prevent recurrence.

  2021cites this paper
• Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti‐epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin‐fold Window Chamber Model

  2020cites this paper
• The Formulation of Methylene Blue Encapsulated , Tc-99 m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy

  2020cites this paper
• The Formulation of Methylene Blue Encapsulated, Tc-99m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy.

  2020cites this paper
• Research advances in integrated theranostic probes for tumor fluorescence visualization and treatment.

  2020cites this paper
• Red and blue light in antitumor photodynamic therapy with chlorin-based photosensitizers: a comparative animal study assisted by optical imaging modalities.

  2020cites this paper
• Hyperbaric Oxygen Combined with 5-Aminolevulinic Acid Photodynamic Therapy Inhibited Human Squamous Cell Proliferation.

  2019cites this paper
• The Formulation of Methylene Blue Encapsulated, Tc-99m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy

  2019cites this paper
• Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines

  2019cites this paper
• TiO2 and its composites as promising biomaterials: a review

  2018influential citation
• Functional Polymer Nanocarriers for Photodynamic Therapy

  2018cites this paper
• Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy

  2018cites this paper
• Immune consequences induced by photodynamic therapy in non-melanoma skin cancers: a review

  2018cites this paper
• New photosensitizers and nanomolecules for photodynamic therapy of cancer

  2018cites this paper
• Trends in Surgical Research in Head and Neck Cancer

  2017cites this paper
• Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

  2017cites this paper
• The alteration of temoporfin distribution in multicellular tumor spheroids by β-cyclodextrins.

  2017cites this paper
• Photodynamic therapy in the upper aerodigestive tract. Overview and outlook

  2016cites this paper
• The potential of photodynamic therapy (PDT)-Experimental investigations and clinical use.

  2016cites this paper
• Photodynamic Efficiency: From Molecular Photochemistry to Cell Death

  2015cites this paper